Related by context. Frequent words. (Click for all words.) 86 dipropionate 71 candidate brentuximab vedotin 70 Panzem R 69 sodium Injection 69 candidates bavituximab 68 Locteron ® 67 R sorafenib tablets 67 FACTIVE R gemifloxacin 66 Inhalation Aerosol 66 Initiates Phase II 66 Receives Orphan Drug Designation 66 refractory chronic lymphocytic 66 inflammatory autoimmune diseases 66 triple VEGF receptor 65 phenylalanine ammonia lyase 65 Genasense ® oblimersen 65 PEG PAL PEGylated recombinant 64 Soliris TM eculizumab 64 chemotherapy induced neutropenia 63 Kuvan R 63 Meets Primary Endpoint 63 Lipid Polymer Micelle LPM 63 anticancer compound 63 vosaroxin 62 Genasense R oblimersen 62 Release Tablets 62 KNS # 62 Hematide TM 62 Drug Candidate 62 AeroLEF R 62 Voreloxin 62 liposomal formulation 62 Phase III Clinical Trial 62 phenylketonuria PKU developed 62 Lubiprostone 62 AzaSite Plus 61 Onalta 61 TELINTRA 61 MKC# 61 cutaneous T 61 Ferumoxytol 61 Alzhemed TM 61 Neo Urinary Conduit 61 MAA submission 61 histone deacetylase HDAC inhibitor 61 Copegus R 61 PLK1 SNALP 60 6R BH4 60 R bortezomib 60 Inhalation Solution 60 JAK inhibitor 60 pseudobulbar affect PBA 60 topical anti infective 60 GVAX R 60 Entereg R 60 ALN TTR 60 Commences Phase 60 Metastatic Melanoma 60 candidate AP# 59 HCV protease inhibitor 59 Fast Track Status 59 ALN TTR# 59 Diabetic Macular Edema 59 Irinotecan 59 multi kinase inhibitor 59 Alinia 59 Pivotal Phase III 59 Initiate Phase 59 Inc Therapeutic Competitors 59 Nexavar ® 59 HepeX B 59 phase IIb clinical 59 secondary hyperparathyroidism 59 Icatibant 59 Recombinant Human 59 Argatroban 59 PRT# 58 novel antibody therapeutics 58 PEG SN# 58 Aloxi R 58 Pivotal Phase 58 SILENOR TM 58 DAVANAT R 58 ApoB SNALP 58 Factor VIIa 58 Single Dose 58 Study Evaluating 58 Tesetaxel 58 Octreotide 58 forodesine 58 Biolex Therapeutics 58 Ixempra 58 BEMA TM Fentanyl 58 Chemophase 58 Anturol 58 NEBIDO R 58 Bicifadine 58 Interferon alpha 58 electrolytically generated source 58 DAVANAT 58 Harbor BioSciences